Long non-coding RNAs involved in cancer metabolic reprogramming

Metabolic reprogramming has now been accepted as a hallmark of cancer. Compared to normal cells, cancer cells exhibit different metabolic features, including increased glucose uptake, aerobic glycolysis, enhanced glutamine uptake and glutaminolysis, altered lipid metabolism, and so on. Cancer metabolic reprogramming, which supports excessive cell proliferation and growth, has been widely regulated by activation of oncogenes or loss of tumor suppressors. Here, we review that long non-coding RNAs (lncRNAs) can affect cancer metabolism by mutual regulation with oncogenes or tumor suppressors. Additionally, the interaction of lncRNAs with crucial transcription factors, metabolic enzymes or microRNAs can also effectively modulate the processes of cancer metabolism. LncRNAs-derived metabolism reprogramming allows cancer cells to maintain deregulated proliferation and withstand hostile microenvironment such as energy stress. Understanding the functions of lncRNAs in cancer metabolic reprogramming that contributes to carcinogenesis and cancer development may help to develop novel and effective strategies for cancer diagnosis, prognosis and treatment.

[1]  B. Amati,et al.  Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis. , 2000, Nucleic acids research.

[2]  S. Maggirwar,et al.  Glycogen Synthase Kinase 3β-Mediated Apoptosis of Primary Cortical Astrocytes Involves Inhibition of Nuclear Factor κB Signaling , 2003, Molecular and Cellular Biology.

[3]  S. Maggirwar,et al.  Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling. , 2003, Molecular and cellular biology.

[4]  Bruce J. Aronow,et al.  Chromatin Immunoprecipitation Assays Footprints in Glycolytic Genes by Evaluation of Myc E-box Phylogenetic Supplemental Material , 2004 .

[5]  M. Armoni,et al.  The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene Expression , 2004, Cancer Research.

[6]  Lewis C Cantley,et al.  The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Wei Zhang,et al.  Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients , 2004, Oncogene.

[8]  Kathryn A. O’Donnell,et al.  Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis , 2005, Molecular and Cellular Biology.

[9]  Oksana Gavrilova,et al.  p53 Regulates Mitochondrial Respiration , 2006, Science.

[10]  Eyal Gottlieb,et al.  TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.

[11]  Oliver Sieber,et al.  A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21 , 2007, Nature Genetics.

[12]  K. Zatloukal,et al.  Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. , 2007, Gastroenterology.

[13]  D. Zhuang,et al.  Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells , 2008, Cell cycle.

[14]  Anthony Mancuso,et al.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.

[15]  Jennifer E. Van Eyk,et al.  c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.

[16]  S. Sugano,et al.  Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species , 2010, Proceedings of the National Academy of Sciences.

[17]  T. Mak,et al.  ROS-mediated p53 induction of Lpin1 regulates fatty acid oxidation in response to nutritional stress. , 2011, Molecular cell.

[18]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[19]  B. Viollet,et al.  AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 , 2011, Nature Cell Biology.

[20]  B. Viollet,et al.  Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy , 2011, Science.

[21]  Navdeep S. Chandel,et al.  AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress , 2012, Nature.

[22]  M. Esteller,et al.  Intronic RNAs mediate EZH2 regulation of epigenetic targets , 2012, Nature Structural &Molecular Biology.

[23]  Dania Daye,et al.  Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis. , 2012, Seminars in cell & developmental biology.

[24]  K. Vousden,et al.  Metabolic Regulation by p53 Family Members , 2013, Cell metabolism.

[25]  Mei Xue,et al.  Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR–STAT3/microRNA143 pathway , 2014, Cancer science.

[26]  P. Molloy,et al.  CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism. , 2014, Biochimica et biophysica acta.

[27]  S. Srivastava,et al.  A long noncoding RNA connects c-Myc to tumor metabolism , 2014, Proceedings of the National Academy of Sciences.

[28]  G. Mills,et al.  Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation. , 2014, Molecular cell.

[29]  Takla Griss,et al.  Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α , 2014, Proceedings of the National Academy of Sciences.

[30]  R. Tibshirani,et al.  Alteration of the lipid profile in lymphomas induced by MYC overexpression , 2014, Proceedings of the National Academy of Sciences.

[31]  Jie Lu,et al.  c-Myc Programs Fatty Acid Metabolism and Dictates Acetyl-CoA Abundance and Fate* , 2014, The Journal of Biological Chemistry.

[32]  Fan Yang,et al.  Reciprocal regulation of HIF-1α and lincRNA-p21 modulates the Warburg effect. , 2014, Molecular cell.

[33]  Xuefeng Yang,et al.  Long-chain acyl-CoA synthetase in fatty acid metabolism involved in liver and other diseases: an update. , 2015, World journal of gastroenterology.

[34]  C. Dang,et al.  MYC, Metabolism, and Cancer. , 2015, Cancer discovery.

[35]  Yue Wang,et al.  Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway. , 2015, Cancer research.

[36]  E. Prochownik,et al.  c-Myc programs fatty acid metabolism and dictates acetyl-CoA abundance and fate. , 2014, The Journal of Biological Chemistry.

[37]  Huan Pang,et al.  Long non-coding RNA UCA1 promotes glutamine metabolism by targeting miR-16 in human bladder cancer. , 2015, Japanese journal of clinical oncology.

[38]  Liqing Zhou,et al.  fMiRNA-192 and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma , 2015, PLoS genetics.

[39]  Howard Y. Chang,et al.  Unique features of long non-coding RNA biogenesis and function , 2015, Nature Reviews Genetics.

[40]  H. Kondoh,et al.  Dysregulated glycolysis as an oncogenic event , 2015, Cellular and Molecular Life Sciences.

[41]  Libing Song,et al.  cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions , 2015, Cell Research.

[42]  Huafeng Zhang,et al.  Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression , 2015, Cellular and Molecular Life Sciences.

[43]  Jennifer B Dennison,et al.  Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis. , 2015, Cell reports.

[44]  J. Neuzil,et al.  MicroRNA in Metabolic Re-Programming and Their Role in Tumorigenesis , 2016, International journal of molecular sciences.

[45]  C. Thompson,et al.  The Emerging Hallmarks of Cancer Metabolism. , 2016, Cell metabolism.

[46]  Jakob Skou Pedersen,et al.  SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism , 2016, Molecular oncology.

[47]  S. Hanash,et al.  Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. , 2016, Molecular cell.

[48]  Jing Wang,et al.  lncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress , 2016, Nature Cell Biology.

[49]  Chi V. Dang,et al.  From Krebs to clinic: glutamine metabolism to cancer therapy , 2016, Nature Reviews Cancer.

[50]  S. Beloribi-Djefaflia,et al.  Lipid metabolic reprogramming in cancer cells , 2016, Oncogenesis.

[51]  N. Hay,et al.  Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? , 2016, Nature Reviews Cancer.

[52]  Howard Y. Chang,et al.  Long Noncoding RNAs in Cancer Pathways. , 2016, Cancer cell.

[53]  B. Wang,et al.  Long non-coding RNA PVT1 promotes glycolysis and tumor progression by regulating miR-497/HK2 axis in osteosarcoma. , 2017, Biochemical and biophysical research communications.

[54]  T. Golub,et al.  LACTB is a tumour suppressor that modulates lipid metabolism and cell state , 2017, Nature.

[55]  S. Venneti,et al.  Glutaminolysis: A Hallmark of Cancer Metabolism. , 2017, Annual review of biomedical engineering.

[56]  Yuquan Wei,et al.  Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer. , 2017, Cancer research.

[57]  Suli Huang,et al.  Overexpression of lncRNA IGFBP4–1 reprograms energy metabolism to promote lung cancer progression , 2017, Molecular Cancer.

[58]  J. Gu,et al.  Energy stress-induced lncRNA FILNC1 represses c-Myc-mediated energy metabolism and inhibits renal tumor development , 2017, Nature Communications.

[59]  G. Qing,et al.  Oncogenic MYC Activates a Feedforward Regulatory Loop Promoting Essential Amino Acid Metabolism and Tumorigenesis. , 2017, Cell reports.

[60]  Xiaodong Zhang,et al.  Promotion of glycolysis by HOTAIR through GLUT1 upregulation via mTOR signaling. , 2017, Oncology reports.

[61]  Shuai Jiang,et al.  MicroRNA regulation and analytical methods in cancer cell metabolism , 2017, Cellular and Molecular Life Sciences.

[62]  I. Ong,et al.  PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis , 2017, Nature Cell Biology.

[63]  Z. Zong,et al.  The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma , 2017, Cell Death & Disease.

[64]  Jin Chen,et al.  mTORC1 and mTORC2 in cancer and the tumor microenvironment , 2016, Oncogene.

[65]  Mian Wu,et al.  The p53‐inducible long noncoding RNA TRINGS protects cancer cells from necrosis under glucose starvation , 2017, The EMBO journal.

[66]  Robert C. Mines,et al.  Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver Metastasis. , 2018, Cell metabolism.

[67]  Yanchun Liang,et al.  LNMICC Promotes Nodal Metastasis of Cervical Cancer by Reprogramming Fatty Acid Metabolism. , 2017, Cancer research.

[68]  Neng Zhu,et al.  Lipid metabolism and carcinogenesis, cancer development. , 2018, American journal of cancer research.

[69]  A. Frankish,et al.  Towards a complete map of the human long non-coding RNA transcriptome , 2018, Nature Reviews Genetics.

[70]  Jamey D. Young,et al.  xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression , 2018, Oncogene.

[71]  Sheng-Cai Lin,et al.  AMPK: Sensing Glucose as well as Cellular Energy Status. , 2017, Cell metabolism.

[72]  R. Shaw,et al.  AMPK: guardian of metabolism and mitochondrial homeostasis , 2017, Nature Reviews Molecular Cell Biology.

[73]  D. Peet,et al.  The Factor Inhibiting HIF Asparaginyl Hydroxylase Regulates Oxidative Metabolism and Accelerates Metabolic Adaptation to Hypoxia , 2018, Cell metabolism.

[74]  Zhimin Lu,et al.  Conversion of PRPS Hexamer to Monomer by AMPK-Mediated Phosphorylation Inhibits Nucleotide Synthesis in Response to Energy Stress. , 2018, Cancer discovery.

[75]  S. Rey,et al.  Cell-Autonomous Metabolic Reprogramming in Hypoxia. , 2017, Trends in cell biology.

[76]  P. Khavari,et al.  The functions and unique features of long intergenic non-coding RNA , 2017, Nature Reviews Molecular Cell Biology.

[77]  E. Prochownik,et al.  The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues , 2018, Front. Endocrinol..

[78]  Yonghong Wang,et al.  ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming , 2017, The Journal of clinical investigation.

[79]  M. Molloy,et al.  Alternative assembly of respiratory complex II connects energy stress to metabolic checkpoints , 2018, Nature Communications.

[80]  P. Lapierre,et al.  Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment , 2018, Cell cycle.

[81]  Hu Li,et al.  NRF2 facilitates breast cancer cell growth via HIF1ɑ-mediated metabolic reprogramming. , 2018, The international journal of biochemistry & cell biology.

[82]  L. de Bari,et al.  Including the mitochondrial metabolism of l-lactate in cancer metabolic reprogramming , 2018, Cellular and Molecular Life Sciences.

[83]  M. Fukayama,et al.  CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity , 2018, Gut.

[84]  M. Murphy,et al.  The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis , 2018, Front. Endocrinol..

[85]  J. Locasale,et al.  Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells , 2018, Nature Cell Biology.